Erik Deitsch
Associated companies: Nutra Pharma Corporation
65Scam score
$0.7MDocumented losses
390Reported victims
Profile
Erik Deitsch served as CEO of Nutra Pharma Corporation, a company involved in securities fraud. He was subject to SEC enforcement action resulting in a final judgment of $680,235 in financial penalties related to fraudulent activities at the pharmaceutical company.
Timeline
- 2020Served as CEO of Nutra Pharma Corporation during period of alleged securities fraud
- 2023SEC issued final judgment against Erik Deitsch for $680,235 in Nutra Pharma fraud case
Frequently Asked Questions
- Who is Erik Deitsch?
- Erik Deitsch served as CEO of Nutra Pharma Corporation, a company involved in securities fraud. He was subject to SEC enforcement action resulting in a final judgment of $680,235 in financial penalties related to fraudulent activities at the pharmaceutical company.
- What is Erik Deitsch's fraud risk rating?
- Erik Deitsch has a scam score of 65/100 (high risk) based on open-source intelligence, regulatory records, and investigative reporting aggregated by ScamTelegraph.
- What companies is Erik Deitsch associated with?
- Erik Deitsch is associated with the following companies or entities: Nutra Pharma Corporation.
- How many investigations mention Erik Deitsch?
- ScamTelegraph has published 4 investigative articles mentioning Erik Deitsch, including: Nutra Pharma Corp settles MyNyloxin fraud with SEC; Avini Health Review: Supplements + illegal medical claims; Nutra Pharma Corp’s CEO settlement tops $79,000.